Long-term outcome with sutureless valves: 12 years of Perceval experience

Szecel, Delphine; Meuris, Bart

doi:10.21037/acs.2020.04.03

Cited by 15 publications

(15 citation statements)

References 7 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Our single center experience with Perceval shows good procedural and clinical result, and low long-term mortality. Both 30-day and late survival in our group is comparable to previous reports and confirm safety and utility of Perceval prosthesis [ 1 – 8 ]. The first observation, by Shrestha et al [ 7 , 8 ] showed safety and efficacy of the Perceval in high-risk patients.…”

supporting

confidence: 90%

Sutureless aortic bioprosthesis: Competitor or alternative for transcatheter aortic valve implantation? Single center experience with Perceval valves

et al. 2022

View full text Add to dashboard Cite

show abstract

supporting

confidence: 90%

Sutureless aortic bioprosthesis: Competitor or alternative for transcatheter aortic valve implantation? Single center experience with Perceval valves

et al. 2022

View full text Add to dashboard Cite

show abstract

“…We highlight a case whereby the Perceval valve continued to have excellent echocardiographic function 9.5 years after implantation. Indeed, we report one of the longest known follow‐ups of a Perceval valve in the current literature 4,5 . This suggests that the Perceval prosthesis may have durability which approaches that of conventional sutured bioprosthetic aortic valves.…”

Section: Discussionmentioning

confidence: 75%

“…Indeed, we report one of the longest known follow-ups of a Perceval valve in the current literature. 4,5 This suggests that the Perceval prosthesis may have durability which approaches that of conventional sutured bioprosthetic aortic valves. This durability may be related to the Perceval valve's stent structure, whereby the proximal and distal ends are spherical and the strut is sinusoidal, which helps contour the valve to the natural shape of the aortic root and sinuses.…”

Section: Discussionmentioning

confidence: 99%

Long‐term durability of a Perceval aortic valve implanted inside a calcified homograft root in a patient with Klippel–Trenaunay–Weber syndrome

Singh

Chaudhuri

Nand

2021

Journal of Cardiac Surgery

View full text Add to dashboard Cite

Background and Aims: Perceval valves are sutureless surgical bioprostheses designed for the aortic position. We report on the use of a Perceval sutureless valve for redo aortic valve replacement inside a heavily calcified homograft root in a patient with Klippel-Trenaunay-Weber syndrome. Materials and Methods: Anonymized patient case data was extracted from hospital electronic records. Results: A now 62-year-old woman with Klippel-Trenaunay-Weber syndrome underwent homograft aortic root replacement for congenital aortic valve dysplasia when she was 39 years old. She re-presented in 2012 with severe symptomatic aortic regurgitation through the homograft root. Computed tomography scanning revealed a heavily calcified homograft root. In order to avoid a high-risk redo root replacement or a challenging sutured aortic valve replacement, she underwent Perceval sutureless aortic valve implantation. As of 9.5 years following Perceval implantation, the bioprosthetic valve function remains excellent, with no transvalvular regurgitation seen. Discussion and Conclusion: This case reveals the value of Perceval valve implantation in redo surgery inside a hostile calcified homograft aortic root. Furthermore, we highlight the long-term durability of the Perceval sutureless bioprosthesis.

show abstract

“…Recently, the clinical outcome of Perceval SU-AVR after 12 years was presented at the 2019 American Association for Thoracic Surgery meeting. 26 It was found to have excellent longevity, and no structural deterioration was observed.…”

Section: Discussionmentioning

confidence: 94%

Clinical and Hemodynamic Outcomes in 121 Patients Who Underwent Perceval Sutureless Aortic Valve Implantation　― Early Results From a Single Korean Institution ―

Kim

Lee

Joo

et al. 2021

Circ J

View full text Add to dashboard Cite

arious new technical approaches have emerged as promising alternatives to conventional aortic valve replacement (AVR) for severe aortic stenosis in the elderly and high-risk patients with multiple comorbidities. Transcatheter aortic valve implantation (TAVI) and rapid deployment or sutureless AVR (SU-AVR) are among the most promising approaches.Several studies on SU-AVR reported that this method could reduce the time of aortic cross-clamp (ACC) and cardiopulmonary bypass (CPB). Moreover, SU-AVR facilitates the use of a minimally invasive approach and concomitant cardiac surgery, and it is associated with excellent hemodynamic and clinical outcomes. 1-6 However, SU-AVR is also associated with a considerably higher rate of permanent pacemaker implantation (PPI) than conventional AVR. Recent studies have proposed several surgical precautions and recommendations, including precise posi-tioning of the guiding sutures or holder angle, evaluation of the extent of annular decalcification required, and reduction in inflation pressure, to avoid conduction disturbance. 7,8 Therefore, our study aimed to assess the early clinical and hemodynamic outcomes in 121 Korean single-institution patients with severe aortic stenosis who underwent Perceval SU-AVR and to introduce a modified guiding suture technique for reducing PPI after SU-AVR. Methods Study PopulationBetween December 2014 and April 2019, 121 consecutive patients presenting with symptomatic severe aortic valve Editorial p ????

show abstract

Long-term outcome with sutureless valves: 12 years of Perceval experience

Cited by 15 publications

References 7 publications

Sutureless aortic bioprosthesis: Competitor or alternative for transcatheter aortic valve implantation? Single center experience with Perceval valves

Sutureless aortic bioprosthesis: Competitor or alternative for transcatheter aortic valve implantation? Single center experience with Perceval valves

Long‐term durability of a Perceval aortic valve implanted inside a calcified homograft root in a patient with Klippel–Trenaunay–Weber syndrome

Clinical and Hemodynamic Outcomes in 121 Patients Who Underwent Perceval Sutureless Aortic Valve Implantation　― Early Results From a Single Korean Institution ―

Contact Info

Product

Resources

About

Long-term outcome with sutureless valves: 12 years of Perceval experience

Cited by 15 publications

References 7 publications

Sutureless aortic bioprosthesis: Competitor or alternative for transcatheter aortic valve implantation? Single center experience with Perceval valves

Sutureless aortic bioprosthesis: Competitor or alternative for transcatheter aortic valve implantation? Single center experience with Perceval valves

Long‐term durability of a Perceval aortic valve implanted inside a calcified homograft root in a patient with Klippel–Trenaunay–Weber syndrome

Clinical and Hemodynamic Outcomes in 121 Patients Who Underwent Perceval Sutureless Aortic Valve Implantation ― Early Results From a Single Korean Institution ―

Contact Info

Product

Resources

About

Clinical and Hemodynamic Outcomes in 121 Patients Who Underwent Perceval Sutureless Aortic Valve Implantation　― Early Results From a Single Korean Institution ―